Large pyoderma gangrenosum in a cancer patient

Infections in Medicine

Volumn 17, Issue 9, 2000, Pages 627-630

  Lopez, Raphael L ^a,b   Greene, John N ^a,c   Sandin, Ramon L ^a,c   DiGuilio, Darren D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H Lee Moffitt Cancer Ctr Res I ^*

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Corticosteroids; Pyoderma gangrenosum

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; CORTICOSTEROID; FENTANYL; FLUCONAZOLE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; ERYTHEMA; HUMAN; HYPERBARIC OXYGEN; LOBECTOMY; LUNG NON SMALL CELL CANCER; MALE; PAIN; PYODERMA GANGRENOSUM; SKIN DEFECT; STAPHYLOCOCCUS SCIURI; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033823209     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Duguid CM, Powell FC. Pyoderma gangrenosum. Clin Dermatol. 1993;11:129-133.
2. Gilman AL, Cohen BA, Urbach AH, et al. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics. 1998;81:846-848.
3. Lear JT, Aterton MT, Byrne JP. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J. 1997;73:65-68.
4. Long CC, Jessop J, Young M, et al. Minimizing the risk of post-operative pyoderma gangrenosum. Br J Dermatol. 1992;127:45-48.
5. Klein JD, Biller JA, Leape LL, Grand RJ. Pyoderma gangrenosum occurring at multiple incision sites. Gastroenterology. 1987;92:810-813.
6. Kitahama A, Roland PY, Kerstein MD. Pyoderma gangrenosum with cutaneous T-cell lymphoma manifested as lower extremity ulcers -case reports. Angiology. 1991;42:498-503.
7. Powell FC, Su D, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34:395-409.
8. Perry HO, Winklemann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972;106:901-905.
9. Schwartz BK, Clendenning WE, Blasik LG. Pyoderma gangrenosum in a patient with HTLV-III antibody. Arch Dermatol. 1986;122:508-509.
10. Van de Kerkhof PCM, Vaan GAM, Holland R. Pyoderma gangrenosum in acute myeloid leukemia during immunosuppression. Eur J Pediatr. 1988;148:34-36.
11. Blanc D, Schreiber M, Racadot E, et al. Pyoderma gangrenosum in an allogenic bone marrow transplant recipient. Clin Exp Dermatol. 1989;14: 376-379.
12. Ross HJ, Moy LA, Kaplan R, et al. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer. 1991;68: 441-443.
13. Suzuki Y, Kuroda K, et al. Unusual cutaneous manifestations of myeloplastic syndrome. Br J Dermatol. 1995;133:483-486.
14. Chow R, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1996;34:1047-1060.
15. Reynolds NJ, Peachey RD. Response of atypical bullous pyoderma gangrenosum to oral minocycline hydrochloride and topical steroids. Acta Denn Venereol (Stockh). 1990;70:538-539.
16. Matis WL, Ellis CN, Griffiths CE, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol. 1992;128:1060-1064.